You are viewing a single comment's thread from:

RE: Johns Hopkins Sept. 2019 Report: Preparedness for a High Impact Respiratory Pathogen Pandemic

in #news5 years ago

According to multiple papers I have seen, using a dead or attenuated virus vaccine for SARS virii, such as SARS2, the current pandemic pathogen, does not result in immunity of test subjects, but higher morbidity (injury) and mortality (death). Every prior attempt to make such a vaccine has caused worse disease and higher numbers of dead than no vaccine.

I do not expect a vaccine anytime soon, as a result of extant research available.

Sort:  

Interesting! Do you have any source links on those? I simply can't keep up with all of this and life in general atm myself. Thanks:)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209347/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335060/

https://www.ncbi.nlm.nih.gov/pubmed/22536382

https://www.ncbi.nlm.nih.gov/pubmed/18941225

https://www.jimmunol.org/content/181/9/6337.long

https://www.ncbi.nlm.nih.gov/pubmed/27269431

https://www.ncbi.nlm.nih.gov/pubmed/17194199

https://jvi.asm.org/content/78/22/12672.abstract

https://science.sciencemag.org/content/303/5660/944.full

I cannot find any research that does not reveal dead or attenuated SARS vaccines cause increased morbidity and mortality. All such studies show that result, including a human trial of RSV (respiratory syncytial virus) in which two infants died.

Nonetheless, China did undertake human trials of SARS vaccines. I had hoped that those trials were responsible for the morbidity and mortality SARS2 caused in China, but the ongoing epidemics in WA, USA, Italy, and Iran prove such SARS vaccine trials were not significant factors in human suffering and death from SARS2.

Coin Marketplace

STEEM 0.15
TRX 0.17
JST 0.028
BTC 68641.27
ETH 2457.35
USDT 1.00
SBD 2.33